as is AbbVie's next-generation hepatitis C combination therapy, Mavyret (glecaprevir+pibrentasvir). Its psoriasis drug risankizumab is under review with the FDA after strong phase 3 results and ...

AbbVie’s revenue grew by $4.5bn, a 16.1% increase from 2017, mostly as a result of strong performances by Mavyret (glecaprevir ... the weak performance of its hepatitis C virus (HCV) drugs ...

Personality disorders—atypical ways of thinking about oneself and relating to other people—are grouped into three clusters: A, B, and C. Cluster B disorders are marked by inappropriate ...

T. Jake Liang describes how meeting a patient with fulminant hepatitis led to a collaboration that resulted in the first infectious clone of hepatitis C virus.

After hours: 7:58:27 pm GMT-5 ...

After hours: January 17 at 7:59:44 p.m. EST ...

Molson Coors Beverage Co. Cl A 7.89% $11.14B Molson Coors Beverage Co. Cl B 2.10% $11.14B ...